Literature DB >> 791152

Prednisone therapy for alopecia areata. A follow-up report.

R J Winter, F Kern, R M Blizzard.   

Abstract

Eighteen patients treated with prednisone on alternate days for varying degrees of alopecia areata (AA) were examined a mean of 15 months after discontinuation of the drug. Despite an initial response to the therapy, long-term benefit was not thought to be substantial. Numerous side effects related either to systemic corticosteroids or to AA were apparent during the course of therapy, as well as at the time of the evaluation reported herein. Acne, obesity, lenticular opacities, mild hypertension, and impaired adrenocorticotropic hormone (ACTH) reserve were among the findings noted. Long-term treatment was not accompanied by an obvious beneficial change in the natural course of AA. Because of the potentially serious side effects and the lack of substantial improvement in the eventual course, alternate-day prednisone therapy is not recommended for long-term use in AA.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 791152

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  9 in total

1.  Long-term intramuscular triamcinolon-acetonide therapy in alopecia areata totalis and universalis.

Authors:  R Michalowski; L Kuczyńska
Journal:  Arch Dermatol Res       Date:  1978-02-15       Impact factor: 3.017

2.  Medium-dose prednisolone pulse therapy in alopecia areata.

Authors:  Pinelopi Efentaki; Andreas Altenburg; Johannes Haerting; Christos C Zouboulis
Journal:  Dermatoendocrinol       Date:  2009-11

Review 3.  Treatments for androgenetic alopecia and alopecia areata: current options and future prospects.

Authors:  V M Meidan; E Touitou
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 4.  Practical management of hair loss.

Authors:  J Shapiro; M Wiseman; H Lui
Journal:  Can Fam Physician       Date:  2000-07       Impact factor: 3.275

Review 5.  Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases.

Authors:  Hideyuki Ujiie; David Rosmarin; Michael P Schön; Sonja Ständer; Katharina Boch; Martin Metz; Marcus Maurer; Diamant Thaci; Enno Schmidt; Connor Cole; Kyle T Amber; Dario Didona; Michael Hertl; Andreas Recke; Hanna Graßhoff; Alexander Hackel; Anja Schumann; Gabriela Riemekasten; Katja Bieber; Gant Sprow; Joshua Dan; Detlef Zillikens; Tanya Sezin; Angela M Christiano; Kerstin Wolk; Robert Sabat; Khalaf Kridin; Victoria P Werth; Ralf J Ludwig
Journal:  Front Med (Lausanne)       Date:  2022-06-09

6.  Antigenic competition as a therapeutic concept for alopecia areata.

Authors:  R Happle
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

7.  Extensive alopecia areata: not necessarily recalcitrant to therapy!

Authors:  Deepal Deshpande; Rachita Dhurat; Punit Saraogi; Sunil Mishra; Chitra Nayak
Journal:  Int J Trichology       Date:  2011-07

Review 8.  Treatment of pediatric alopecia areata: A systematic review.

Authors:  Virginia R Barton; Atrin Toussi; Smita Awasthi; Maija Kiuru
Journal:  J Am Acad Dermatol       Date:  2021-04-30       Impact factor: 15.487

9.  Comparison of High-Dose Corticosteroid Pulse Therapy and Combination Therapy Using Oral Cyclosporine with Low-Dose Corticosteroid in Severe Alopecia Areata.

Authors:  In Kwon Yeo; Eun Jung Ko; Yeon A No; Ee Seok Lim; Kui Young Park; Kapsok Li; Beom Joon Kim; Seong Jun Seo; Myeung Nam Kim; Chang Kwun Hong
Journal:  Ann Dermatol       Date:  2015-12-07       Impact factor: 1.444

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.